2521. VE707, a Defined Live Biotherapeutic Product for Prevention of Infection by Multidrug-Resistant Gram-Negative Bacteria

BACKGROUND: Infections with multidrug-resistant organisms (MDRO) are increasing at an alarming rate in hospitals worldwide. MDRO infections are often preceded by asymptomatic intestinal colonization and growth by the MDRO. Treatments such as non-absorbable antibiotics and fecal microbiota transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Medlock, Gregory, Felix, Cintia, Alsharif, Wajd, Cornacchione, Lou, Schinn, Matthew, Watson, Andrea, Bedard-Shurtleff, Suzanne, Norman, Jason, Faith, Jeremiah, Kuijper, Ed J, Olle, Bernat, Caballero, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677003/
http://dx.doi.org/10.1093/ofid/ofad500.2139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677003/
http://dx.doi.org/10.1093/ofid/ofad500.2139

Ejemplares similares